Abcodia

Abcodia's primary focus is the study of biomarkers for cancer.

On 18 September 2013 Abcodia announced that it had entered into an agreement for an exclusive license for the Risk of Ovarian Cancer Algorithm (ROCA), a test studied for screening of ovarian cancer. The use of this test is not recommended by the FDA as there is no evidence it is either safe or effective.{{cite web|title=Ovarian Cancer Screening Tests: Safety Communication – FDA Recommends Against Use|url=https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm519540.htm|publisher=Food and Drug Administration|accessdate=9 September 2016|date=7 September 2016}}

Abcodia is a spin-out from University College London and was founded in 2010. UCL granted Abcodia the exclusive commercialisation rights to a serum collection created by clinical scientists at the Institute for Women's Health at UCL. The serum biobank was formed as part of the UK Collaborative Trial of Ovarian Cancer Screening UKCTOCS, which was led by Professor Ian Jacobs and Professor Usha Menon.{{Cite journal | last1 = Burnell | first1 = M. | last2 = Gentry-Maharaj | first2 = A. | last3 = Ryan | first3 = A. | last4 = Apostolidou | first4 = S. | last5 = Habib | first5 = M. | last6 = Kalsi | first6 = J. | last7 = Skates | first7 = S. | last8 = Parmar | first8 = M. | last9 = Seif | first9 = M. W. | last10 = Amso | first10 = N. N. | last11 = Godfrey | first11 = K. | last12 = Oram | first12 = D. | last13 = Herod | first13 = J. | last14 = Williamson | first14 = K. | last15 = Jenkins | first15 = H. | last16 = Mould | first16 = T. | last17 = Woolas | first17 = R. | last18 = Murdoch | first18 = J. | last19 = Dobbs | first19 = S. | last20 = Leeson | first20 = S. | last21 = Cruickshank | first21 = D. | last22 = Campbell | first22 = S. | last23 = Fallowfield | first23 = L. | last24 = Jacobs | first24 = I. | last25 = Menon | first25 = U. | title = Impact on mortality and cancer incidence rates of using random invitation from population registers for recruitment to trials | doi = 10.1186/1745-6215-12-61 | journal = Trials | volume = 12 | pages = 61 | year = 2011 | pmid = 21362184| pmc =3058013 | doi-access = free }}{{cite journal |doi=10.1038/sj.bjc.6605809 |title=Awareness of ovarian cancer risk factors, beliefs and attitudes towards screening: Baseline survey of 21 715 women participating in the UK Collaborative Trial of Ovarian Cancer Screening |year=2010 |last1=Fallowfield |first1=L |last2=Fleissig |first2=A |last3=Barrett |first3=J |last4=Menon |first4=U |last5=Jacobs |first5=I |last6=Kilkerr |first6=J |last7=Farewell |first7=V |journal=British Journal of Cancer |volume=103 |issue=4 |pages=454–61 |pmid=20648018 |last8=Ukctocs |first8=Trialists |pmc=2939792}}{{Cite journal | last1 = Jacobs | first1 = I. | last2 = Gentry-Maharaj | first2 = A. | last3 = Burnell | first3 = M. | last4 = Manchanda | first4 = R. | last5 = Singh | first5 = N. | last6 = Sharma | first6 = A. | last7 = Ryan | first7 = A. | last8 = Seif | first8 = M. W. | last9 = Amso | first9 = N. N. | last10 = Turner | first10 = G. | last11 = Brunell | first11 = C. | last12 = Fletcher | first12 = G. | last13 = Rangar | first13 = R. | last14 = Ford | first14 = K. | last15 = Godfrey | first15 = K. | last16 = Lopes | first16 = A. | last17 = Oram | first17 = D. | last18 = Herod | first18 = J. | last19 = Williamson | first19 = K. | last20 = Scott | first20 = I. | last21 = Jenkins | first21 = H. | last22 = Mould | first22 = T. | last23 = Woolas | first23 = R. | last24 = Murdoch | first24 = J. | last25 = Dobbs | first25 = S. | last26 = Leeson | first26 = S. | last27 = Cruickshank | first28 = S. J. | first29 = L. | last30 = Parmar | first30 = M. | last28 = Skates | last29 = Fallowfield | first27 = D. | title = Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: A case-control study within the UKCTOCS cohort | doi = 10.1016/S1470-2045(10)70268-0 | journal = The Lancet Oncology | volume = 12 | issue = 1 | pages = 38–48 | year = 2011 | pmid = 21147030| doi-access = free | url = https://qmro.qmul.ac.uk/xmlui/bitstream/123456789/15120/1/Jacobs%20Sensitivity%20of%20transvaginal%20ultrasound%20screening%20for%20endometrial%20cancer%20in%20postmenopausal%20women%3a%20a%20case-control%20study%20within%20the%20UKCTOCS%20cohort%202010%20Published.pdf }}

December 2012, Abcodia won four prizes at the UK Startup Awards 2012 annual awards: Angel or VC-backed Business of the Year, Innovative Business of the Year, and Business Woman of the Year for its CEO Dr Julie Barnes. It also won the overall NatWest Startups Business of the Year for its work in cancer screening.{{cite news|url=http://startups.co.uk/startups-awards/natwest-startups-business-of-the-year-2012/|title=NatWest Startups Business of the Year 2012: Abcodia|work=Startups.co.uk|accessdate=2014-05-06}}

{{reflist}}

• [http://www.abcodia.com Abcodia website]

Category:Biotechnology companies of the United Kingdom

Category:Biotechnology companies established in 2010

Category:2010 establishments in England